Last 12 months
Inside the activity.
0 purchase rows · 49 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 10 |
| Jan 2026 | 0 | 4 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 12 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2025 Filed Mar 3, 2025 22:45 UTC |
Hopman MarkChief Commercial Officer
|
GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-006234 · form4-03032025_050311.xml · nonDerivative · entry 1 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 22:45 UTC |
Mensinger MikeChief Product Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 52,000 | $0.00 Strike: $19.91 | $0.00 |
DisclosureSEC source: 0001415889-25-006232 · form4-03032025_050306.xml · derivative · entry 2 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 52,000 shares Expires 2035-02-26 F2 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from February 27, 2025. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 22:45 UTC |
Mensinger MikeChief Product Officer
|
GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-006232 · form4-03032025_050306.xml · nonDerivative · entry 1 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,019 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 22:45 UTC |
Feider StephenChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 71,000 | $0.00 Strike: $19.91 | $0.00 |
DisclosureSEC source: 0001415889-25-006231 · form4-03032025_050304.xml · derivative · entry 2 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,000 Underlying: Common Stock · 71,000 shares Expires 2035-02-26 F2 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from February 27, 2025. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 22:45 UTC |
Feider StephenChief Financial Officer
|
GrantCommon Stock | 47,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-006231 · form4-03032025_050304.xml · nonDerivative · entry 1 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,000 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 22:45 UTC |
Saint SeanDirector · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 163,000 | $0.00 Strike: $19.91 | $0.00 |
DisclosureSEC source: 0001415889-25-006230 · form4-03032025_050301.xml · derivative · entry 2 Saint Sean · CIK 0002048593 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,000 Underlying: Common Stock · 163,000 shares Expires 2035-02-26 F2 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from February 27, 2025. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 22:45 UTC |
Saint SeanDirector · President & CEO
|
GrantCommon Stock | 108,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-006230 · form4-03032025_050301.xml · nonDerivative · entry 1 Saint Sean · CIK 0002048593 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,000 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Palasis MariaDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 9,137 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001415889-25-002821 · form4-02032025_080215.xml · derivative · entry 1 Palasis Maria · CIK 0001810701 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,137 Underlying: Common Stock · 9,137 shares Expires 2033-01-24 F1 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from August 15, 2022. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 16:49 UTC | ConversionSeries E Preferred Stock · Derivative | 2,901,599 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-012403 · ownership.xml · derivative · entry 3 Wellington Hadley Harbor Aggregator IV, L.P. · CIK 0002053997 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,901,599 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the initial public offering, each share of Series E Preferred Stock (the "Preferred Stock") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date. F1 · derivative.exercise_date: Immediately prior to the closing of the initial public offering, each share of Series E Preferred Stock (the "Preferred Stock") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date. F1 · derivative.expiration_date: Immediately prior to the closing of the initial public offering, each share of Series E Preferred Stock (the "Preferred Stock") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date. Read SEC document |
|
| January 31, 2025 Filed Feb 3, 2025 16:49 UTC | PurchaseCommon Stock | 1,000,000 | $17.00 | $17,000,000.00 |
DisclosureSEC source: 0000950170-25-012403 · ownership.xml · nonDerivative · entry 2 Wellington Hadley Harbor Aggregator IV, L.P. · CIK 0002053997 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,901,599 F2 · shares: Shares acquired in a private placement pursuant to the terms of a Common Stock Purchase Agreement dated January 21, 2025. Read SEC document |
|
| January 31, 2025 Filed Feb 3, 2025 16:49 UTC | ConversionCommon Stock | 2,901,599 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-012403 · ownership.xml · nonDerivative · entry 1 Wellington Hadley Harbor Aggregator IV, L.P. · CIK 0002053997 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,901,599 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Immediately prior to the closing of the initial public offering, each share of Series E Preferred Stock (the "Preferred Stock") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date. Read SEC document |
|
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Russell Steven JonChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 90,637 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001415889-25-002823 · form4-02032025_080220.xml · derivative · entry 3 Russell Steven Jon · CIK 0002051384 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,637 Underlying: Common Stock · 90,637 shares Expires 2035-01-28 F4 · derivative.exercise_date: Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Russell Steven JonChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 53,584 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001415889-25-002823 · form4-02032025_080220.xml · derivative · entry 2 Russell Steven Jon · CIK 0002051384 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,584 Underlying: Common Stock · 53,584 shares Expires 2033-09-13 F3 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Russell Steven JonChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 81,217 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001415889-25-002823 · form4-02032025_080220.xml · derivative · entry 1 Russell Steven Jon · CIK 0002051384 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,217 Underlying: Common Stock · 81,217 shares Expires 2032-12-14 F1 · derivative.exercise_date: One-fourth of the shares subject to this option shall vest one year after November 14, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Saint SeanDirector · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 467,944 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001415889-25-002822 · form4-02032025_080218.xml · derivative · entry 5 Saint Sean · CIK 0002048593 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 467,944 Underlying: Common Stock · 467,944 shares Expires 2035-01-28 F6 · derivative.exercise_date: Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Saint SeanDirector · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 54,911 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001415889-25-002822 · form4-02032025_080218.xml · derivative · entry 4 Saint Sean · CIK 0002048593 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,911 Underlying: Common Stock · 54,911 shares Expires 2033-09-13 F5 · derivative.exercise_date: The shares subject to this option shall vest in 12 equal monthly installments measured four years after August 15, 2022. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Saint SeanDirector · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 494,198 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001415889-25-002822 · form4-02032025_080218.xml · derivative · entry 3 Saint Sean · CIK 0002048593 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 494,198 Underlying: Common Stock · 494,198 shares Expires 2033-09-13 F4 · derivative.exercise_date: One-fourth of the shares subject to this option shall vest one year after August 15, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Saint SeanDirector · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 83,268 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001415889-25-002822 · form4-02032025_080218.xml · derivative · entry 2 Saint Sean · CIK 0002048593 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,268 Underlying: Common Stock · 83,268 shares Expires 2032-07-31 F3 · derivative.exercise_date: The shares subject to this option shall vest in 12 equal monthly installments measured four years after August 1, 2022. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Saint SeanDirector · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 749,445 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001415889-25-002822 · form4-02032025_080218.xml · derivative · entry 1 Saint Sean · CIK 0002048593 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 749,445 Underlying: Common Stock · 749,445 shares Expires 2032-07-31 F1 · derivative.exercise_date: One-fourth of the shares subject to this option shall vest one year after August 1, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Lezack AdamDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 9,137 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001415889-25-002820 · form4-02032025_080213.xml · derivative · entry 1 Lezack Adam · CIK 0002048466 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,137 Underlying: Common Stock · 9,137 shares Expires 2033-12-11 F1 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from December 12, 2023. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Mensinger MikeChief Product Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 110,278 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001415889-25-002819 · form4-02032025_080211.xml · derivative · entry 9 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,278 Underlying: Common Stock · 110,278 shares Expires 2025-01-28 F7 · derivative.exercise_date: Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts. F6 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Mensinger MikeChief Product Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 236,553 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001415889-25-002819 · form4-02032025_080211.xml · derivative · entry 8 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,553 Underlying: Common Stock · 236,553 shares Expires 2033-09-13 F5 · derivative.exercise_date: One-fourth of the shares subject to this option shall vest one year after August 1, 2023, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof. F6 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Mensinger MikeChief Product Officer
|
OtherClass B Common Stock Warrant (right to buy) · Derivative | 10,575 | $0.00 Strike: $0.02 | $0.00 |
DisclosureSEC source: 0001415889-25-002819 · form4-02032025_080211.xml · derivative · entry 7 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,575 shares Expires 2033-08-27 F4 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this warrant was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Mensinger MikeChief Product Officer
|
ConversionClass B Common Stock Warrant (right to buy) · Derivative | 10,575 | $0.00 Strike: $0.02 | $0.00 |
DisclosureSEC source: 0001415889-25-002819 · form4-02032025_080211.xml · derivative · entry 6 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,575 Underlying: Common Stock · 10,575 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this warrant was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Mensinger MikeChief Product Officer
|
ConversionSeries D Preferred Stock · Derivative | 15,107 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-002819 · form4-02032025_080211.xml · derivative · entry 5 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,107 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the initial public offering, each share of Series D Preferred Stock (the "Preferred Stock") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date. F1 · price: Immediately prior to the closing of the initial public offering, each share of Series D Preferred Stock (the "Preferred Stock") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date. F1 · derivative.exercise_date: Immediately prior to the closing of the initial public offering, each share of Series D Preferred Stock (the "Preferred Stock") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date. F1 · derivative.expiration_date: Immediately prior to the closing of the initial public offering, each share of Series D Preferred Stock (the "Preferred Stock") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date. F1 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Series D Preferred Stock (the "Preferred Stock") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Mensinger MikeChief Product Officer
|
PurchaseCommon Stock | 33,350 | $17.00 | $566,950.00 |
DisclosureSEC source: 0001415889-25-002819 · form4-02032025_080211.xml · nonDerivative · entry 4 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,019 F3 · kind: The shares were purchased in the Issuer's initial public offering. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Mensinger MikeChief Product Officer
|
SaleCommon Stock | 13 | $17.00 | $221.00 |
DisclosureSEC source: 0001415889-25-002819 · form4-02032025_080211.xml · nonDerivative · entry 3 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,669 F2 · kind: On January 31, 2025, the reporting person exercised a warrant to purchase 10,575 shares of Issuer's common stock for $0.02 per share. The Reporting Person paid the exercise price on a cashless basis, resulting in withholding of 13 of the warrant shares to pay the exercise price and issuing to the Reporting Person the remaining 10,562 shares. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Mensinger MikeChief Product Officer
|
OtherCommon Stock | 10,575 | $0.02 | $211.50 |
DisclosureSEC source: 0001415889-25-002819 · form4-02032025_080211.xml · nonDerivative · entry 2 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,682 Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Mensinger MikeChief Product Officer
|
ConversionCommon Stock | 15,107 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-002819 · form4-02032025_080211.xml · nonDerivative · entry 1 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,107 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Immediately prior to the closing of the initial public offering, each share of Series D Preferred Stock (the "Preferred Stock") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Jones ChristyDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 48,730 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001415889-25-002818 · form4-02032025_080208.xml · derivative · entry 3 Jones Christy · CIK 0002048467 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,730 Underlying: Common Stock · 48,730 shares Expires 2032-07-26 F4 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from July 27, 2022. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Jones ChristyDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 9,137 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001415889-25-002818 · form4-02032025_080208.xml · derivative · entry 2 Jones Christy · CIK 0002048467 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,137 Underlying: Common Stock · 9,137 shares Expires 2031-12-07 F3 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from July 20, 2021. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Jones ChristyDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 9,137 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001415889-25-002818 · form4-02032025_080208.xml · derivative · entry 1 Jones Christy · CIK 0002048467 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,137 Underlying: Common Stock · 9,137 shares Expires 2031-12-07 F1 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from April 27, 2021. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Hopman MarkChief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 47,775 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001415889-25-002817 · form4-02032025_080206.xml · derivative · entry 5 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,775 Underlying: Common Stock · 47,775 shares Expires 2035-01-28 F6 · derivative.exercise_date: Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Hopman MarkChief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 39,424 | $0.00 Strike: $10.74 | $0.00 |
DisclosureSEC source: 0001415889-25-002817 · form4-02032025_080206.xml · derivative · entry 4 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,424 Underlying: Common Stock · 39,424 shares Expires 2034-09-29 F5 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from September 30, 2024. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Hopman MarkChief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 17,765 | $0.00 Strike: $8.51 | $0.00 |
DisclosureSEC source: 0001415889-25-002817 · form4-02032025_080206.xml · derivative · entry 3 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,765 Underlying: Common Stock · 17,765 shares Expires 2033-12-31 F4 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from January 1, 2024. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Hopman MarkChief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 37,229 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001415889-25-002817 · form4-02032025_080206.xml · derivative · entry 2 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,229 Underlying: Common Stock · 37,229 shares Expires 2033-09-13 F3 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Hopman MarkChief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 83,242 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001415889-25-002817 · form4-02032025_080206.xml · derivative · entry 1 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,242 Underlying: Common Stock · 83,242 shares Expires 2033-07-26 F1 · derivative.exercise_date: One-fourth of the shares subject to this option shall vest one year after March 20, 2023, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Feider StephenChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 186,203 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001415889-25-002816 · form4-02032025_080204.xml · derivative · entry 3 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,203 Underlying: Common Stock · 186,203 shares Expires 2035-01-28 F4 · derivative.exercise_date: Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Feider StephenChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 109,695 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001415889-25-002816 · form4-02032025_080204.xml · derivative · entry 2 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,695 Underlying: Common Stock · 109,695 shares Expires 2033-09-13 F3 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
Feider StephenChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 166,542 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001415889-25-002816 · form4-02032025_080204.xml · derivative · entry 1 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,542 Underlying: Common Stock · 166,542 shares Expires 2032-07-31 F1 · derivative.exercise_date: One-fourth of the shares subject to this option shall vest one year after August 1, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
CARNEY SEANDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 30,456 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001415889-25-002815 · form4-02032025_080201.xml · derivative · entry 2 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,456 Underlying: Common Stock · 30,456 shares Expires 2032-07-26 F3 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from July 27, 2022. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:30 UTC |
CARNEY SEANDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 55,837 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001415889-25-002815 · form4-02032025_080201.xml · derivative · entry 1 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,837 Underlying: Common Stock · 55,837 shares Expires 2030-05-14 F1 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from February 12, 2020. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:34 UTC |
Russell Steven JonChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 90,637 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001415889-25-002484 · form4-01312025_090101.xml · derivative · entry 1 Russell Steven Jon · CIK 0002051384 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,637 Underlying: Class B Common Stock · 90,637 shares Expires 2035-01-28 F1 · derivative.exercise_date: Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:35 UTC |
Saint SeanDirector · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 467,944 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001415889-25-002490 · form4-01312025_090147.xml · derivative · entry 1 Saint Sean · CIK 0002048593 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 467,944 Underlying: Class B Common Stock · 467,944 shares Expires 2035-01-28 F1 · derivative.exercise_date: Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:32 UTC |
Mensinger MikeChief Product Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 110,278 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001415889-25-002481 · form4-01312025_090141.xml · derivative · entry 1 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,278 Underlying: Class B Common Stock · 110,278 shares Expires 2035-01-28 F1 · derivative.exercise_date: Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:31 UTC |
Hopman MarkChief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 47,775 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001415889-25-002480 · form4-01312025_090153.xml · derivative · entry 1 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,775 Underlying: Class B Common Stock · 47,775 shares Expires 2035-01-28 F1 · derivative.exercise_date: Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:30 UTC |
Feider StephenChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 186,203 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001415889-25-002479 · form4-01312025_090132.xml · derivative · entry 1 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,203 Underlying: Class B Common Stock · 186,203 shares Expires 2035-01-28 F1 · derivative.exercise_date: Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts. F2 · derivative.underlying: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.